banner
JAYPEE PHARMACARE

GST : 24BAYPS0913F1ZI

2mg Bortenat Bortezomib Injection
2mg Bortenat Bortezomib Injection
2mg Bortenat Bortezomib Injection
2mg Bortenat Bortezomib Injection

2mg Bortenat Bortezomib Injection

Price 11300.0 INR/ Piece

MOQ : 10 Pieces

2mg Bortenat Bortezomib Injection Specification

  • Life Span
  • 24 months from date of manufacture
  • Pacakaging (Quantity Per Box)
  • 1 vial per box
  • Dosage Form
  • Injection
  • Brand Name
  • Bortenat
  • Packaging Type
  • Vial
  • Salt Composition
  • Bortezomib 2mg
  • Origin of Medicine
  • India
  • Indication
  • Multiple myeloma, Mantle cell lymphoma
  • Drug Type
  • Allopathic
  • Ingredients
  • Bortezomib
  • Physical Form
  • Lyophilized Powder
  • Function
  • Recommended For
  • Patients with multiple myeloma or mantle cell lymphoma
  • Dosage
  • As prescribed by the physician, typically 1.3 mg/m2
  • Dosage Guidelines
  • To be administered intravenously or subcutaneously under medical supervision
  • Suitable For
  • Adults
  • Storage Instructions
  • Store below 25C, protect from light
  • Shelf Life (From Date of Manufacture)
  • 24 months
  • Reconstitution
  • Reconstitute with 2.4 ml 0.9% Sodium Chloride Injection
  • Molecular Formula
  • C19H25BN4O4
  • Drug Class
  • Proteasome Inhibitor
  • Marketed By
  • Natco Pharma Ltd.
  • Route of Administration
  • IV or SC
  • Prescription Required
  • Yes
  • International Brand Equivalent
  • Velcade
  • Color
  • White to off-white lyophilized powder
 

2mg Bortenat Bortezomib Injection Trade Information

  • Minimum Order Quantity
  • 10 Pieces
  • Supply Ability
  • 1000 Pieces Per Month
  • Delivery Time
  • 7 Days
 

About 2mg Bortenat Bortezomib Injection

Strength 2mg
Form Injection
Manufacturer Natco
Brand Bortenat
Packaging Type Box
Medicine Type Allopathic
Application To Treat Multiple Myeloma

Bortenat 2mg & 3.5 mg Injection is used in the treatment of multiple myeloma and mantle-cell lymphoma. It shows its working by stopping or slowing down the growth of cancer cells.

Bortenat 2mg & 3.5 mg Injection is given as an injection by a qualified medical professional. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.

Fatigue, nausea, vomiting, and loss of appetite are some common side effects of this medicine. You may be advised to drink plenty of fluids every day during the treatment. You should not drive or operate machinery as medicine may cause tiredness and dizziness. This medicine may reduce the number of blood cells (decrease red blood and white blood cells) in your blood, thereby, increasing the susceptibility to infections. Regular blood tests are required to check your blood cells along with heart, liver, and blood uric acid levels.

Effective Cancer Treatment for Adults

Bortenat Bortezomib Injection is formulated for adults diagnosed with multiple myeloma and mantle cell lymphoma. As a potent proteasome inhibitor, it interferes with cancer cell growth, making it a vital option in oncology care. Its efficacy aligns with established international standards, providing patients in India with a reliable equivalent to Velcade.


Safe Handling and Administration

This injection is supplied as a lyophilized powder and must be reconstituted with 2.4 ml of 0.9% Sodium Chloride Injection prior to use. Administration is strictly performed by healthcare professionals via intravenous (IV) or subcutaneous (SC) routes. Patients are advised never to self-administer and to always follow their prescribed treatment regimen under medical supervision.


Convenient and Reliable Packaging

Bortenat comes in a single-vial package, ensuring accurate dosing and minimal waste. With a shelf life of 24 months from the manufacturing date, it provides flexibility for both inventory management and patient scheduling. Proper storage below 25C and protection from light preserve its potency throughout its lifespan.

FAQ's of 2mg Bortenat Bortezomib Injection:


Q: How should Bortenat Bortezomib Injection be reconstituted and administered?

A: Bortenat Bortezomib Injection should be reconstituted with 2.4 ml of 0.9% Sodium Chloride Injection. Administration must be carried out by a qualified healthcare professional, using either intravenous (IV) or subcutaneous (SC) routes, as per the physician's instructions.

Q: What conditions is Bortenat Bortezomib Injection recommended for?

A: This injection is primarily indicated for the treatment of adults with multiple myeloma or mantle cell lymphoma. It works by inhibiting proteasomes, thereby disrupting cancer cell growth and survival.

Q: When should the injection be administered, and what is the typical dosage?

A: Bortenat is administered based on a physician's prescription, typically at a dosage of 1.3 mg/m2, according to individual treatment protocols. The exact timing and frequency will be determined by your healthcare provider based on your specific needs and response to therapy.

Q: Where should Bortenat Bortezomib Injection be stored before use?

A: The injection must be stored below 25C and protected from light to maintain its stability and effectiveness. Always keep it in its original packaging until ready to use and out of reach of children.

Q: What are the benefits of using Bortenat Bortezomib Injection in cancer treatment?

A: Bortenat Bortezomib offers a targeted approach for treating multiple myeloma and mantle cell lymphoma. By inhibiting proteasomal activity, it effectively inhibits tumor growth and supports improved patient outcomes as part of chemotherapy regimens.

Q: Is a prescription required to obtain Bortenat Bortezomib Injection?

A: Yes, Bortenat Bortezomib Injection is a prescription-only medication and can only be administered under the supervision of a healthcare professional.

Q: Who manufactures and markets Bortenat Bortezomib Injection?

A: This injection is manufactured and marketed by Natco Pharma Ltd., India, and serves as a locally available equivalent to the international brand Velcade.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Anti Cancer Injection Category

100mg Behdit Bendamustine Hydrochloride Injection

100mg Behdit Bendamustine Hydrochloride Injection

Price 3650.0 INR / Piece

Minimum Order Quantity : 10 Pieces

Ingredients : Bendamustine Hydrochloride 100mg

Storage Instructions : Store below 25C. Protect from light and keep out of reach of children.

Indication : Chronic lymphocytic leukemia (CLL), NonHodgkins lymphoma (NHL)

Recommended For : Treatment of chronic lymphocytic leukemia (CLL), NonHodgkins lymphoma (NHL)

15 Units Bleocel Bleomycin Injection

15 Units Bleocel Bleomycin Injection

Price 590.0 INR / Piece

Minimum Order Quantity : 10 Pieces

Ingredients : Bleomycin Sulphate

Storage Instructions : Store below 25C, protect from light

Indication : Treatment of various cancers such as Hodgkins disease, squamous cell carcinoma, testicular cancer, and others

Recommended For : Adults & Cancer Patients

1mg Arsenox Arsenic Trioxide Injection

1mg Arsenox Arsenic Trioxide Injection

Price 810.0 INR / Piece

Minimum Order Quantity : 10 Pieces

Ingredients : Arsenic Trioxide 1mg/ml

Storage Instructions : Store below 25C, protect from light

Indication : Induction and consolidation treatment of Acute Promyelocytic Leukemia (APL)

Recommended For : Adults and pediatric patients with relapsed or refractory Acute Promyelocytic Leukemia (APL)

Rasburicase 1.5 Mg Injection

Rasburicase 1.5 Mg Injection

Price 8800.0 INR / Piece

Minimum Order Quantity : 10 Pieces

Ingredients : Rasburicase

Storage Instructions : Store in a refrigerator (2C8C). Do not freeze.

Indication : Tumor lysis syndromeinduced hyperuricemia

Recommended For : Adults and children with hyperuricemia associated with malignancy



Back to top